Biotech Desk Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-06-2024
- Paid Up Capital ₹ 3.50 M
as on 23-06-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 23-06-2024
- Revenue 5.33%
(FY 2022)
- Profit -37.88%
(FY 2022)
- Ebitda -15.83%
(FY 2022)
- Net Worth 51.36%
(FY 2022)
- Total Assets 14.69%
(FY 2022)
About Biotech Desk
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹1.50 Cr.
Shradha Goenka and Manav Sharma serve as directors at the Company.
- CIN/LLPIN
U24239TG2003PTC040901
- Company No.
040901
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biotech Desk Private Limited offer?
Biotech Desk Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Nutraceuticals & Dietary Supplements, Dietary Supplements.
Who are the key members and board of directors at Biotech Desk?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shradha Goenka  | Managing Director | 28-Apr-2003 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manav Sharma | Director | 25-Feb-2023 | Current |
Financial Performance of Biotech Desk.
Biotech Desk Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.33% increase. The company also saw a substantial fall in profitability, with a 37.88% decrease in profit. The company's net worth Soared by an impressive increase of 51.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech Desk?
In 2021, Biotech Desk had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 11 Nov 2022 | ₹1.50 Cr | Open |
How Many Employees Work at Biotech Desk?
Biotech Desk has a workforce of 22 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech Desk, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech Desk's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
